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Cholecystitis is one of the leading causes of emergency surgical 
interventions; the occurrence of metastases to the gallbladder is rare 
and has only been reported in the literature exceptionally. Metastatic 
breast cancer to the gallbladder is even less frequent; in fact, breast 
cancer usually metastasizes to bone, lung, lymph nodes, liver and 
brain. We report the case of an 83-year-old female patient with a 
previous history of breast surgery with axillary dissection in 1997, 
followed by adjuvant chemotherapy due to invasive ductal carcinoma 
of the left breast. The patient was admitted at the emergency 
department for sepsis and an episode of acute kidney failure, anuria 
and fever. Right-upper quadrant abdominal pain triggered by food 
intake and abdominal tenderness was also present, placing the 
diagnostic suspicion of biliary sepsis due to acute cholecystitis. The 
histological examination of the surgical specimen highlighted the 
presence of metastasis from an infiltrating ductal breast carcinoma 
with positive hormone receptors. We also report here the results of a 
review of the literature looking at articles describing cases of 
gallbladder metastasis from breast cancer.
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Introduction
Cholecystitis is one of the leading causes of emergency surgi-
cal interventions. The diagnosis of acute cholecystitis is usually 
based on physical examination, laboratory tests and abdominal 
ultrasound. The surgical options for cholecystitis are either 
open and laparoscopic cholecystectomy; the latter is nowadays 
considered the gold standard of treatment. Surgical specimens 
must be sent for histopathological examination to rule out 
cancer1.
The occurrence of metastases to the gallbladder is rare and has 
only been reported in the literature exceptionally2. Primary 
tumors can metastasize to the gallbladder either by proximity, 
such as hepatocellular carcinoma and pancreatic carcinoma, or 
by blood diffusion3.
Chan reported, in a series of 7910 cholecystectomy specimens, 
that 36 cases of metastatic carcinoma were found, more often sec-
ondary to the stomach, lower gastrointestinal tract, liver, kidney 
or skin (malignant melanoma) cancer4. Another more recent 
study shows that metastasis to the gallbladder accounted for 7/225 
(3.1%) of the incidental gallbladder malignancies5. Metastasis 
from breast cancer to the gallbladder is even less common; in 
fact, breast cancer usually metastasizes to bone, lung, lymph 
nodes, liver and brain.
We describe here the case of a patient who underwent chole-
cystectomy for acute cholecystitis with gallbladder metastasis 
from breast cancer. Subsequently, we present the results of a 
literature search concerning this disease.
Case report
We report the case of an 83-year-old female patient with a previ-
ous history of breast surgery with axillary dissection in 1997, 
followed by adjuvant chemotherapy due to invasive ductal 
carcinoma of the left breast. The family history was negative 
for neoplastic diseases, both mammary and belonging to the 
gastrointestinal tract. Oncological follow-up was negative, and 
the patient considered disease-free for almost 15 years. Dur-
ing 2012, an X-ray of the spine, performed for the appearance 
of lumbar pain, revealed the presence of vertebral metastases. 
The patient was treated with radiotherapy and spinal stabili-
zation. In addition to this, a deep venous thrombosis episode 
was reported in 2017, and treated with anticoagulant therapy. 
In the same year, multiple myeloma associated with mild chronic 
kidney disease was diagnosed. Neither myeloma nor kidney 
disease had requested specific treatments.
In July 2018, the patient was admitted to the emergency depart-
ment for sepsis and an episode of acute kidney failure, anuria and 
fever. Right-upper quadrant abdominal pain triggered by food 
intake and abdominal tenderness was also present, placing the 
diagnostic suspicion of biliary sepsis due to acute cholecystitis.
This condition was conservatively treated with intravenous anti-
biotic therapy with renal adjusted dose of piperacillin-tazobactam 
and hemodialysis for two weeks. Subsequently, kidney func-
tion improved, diuresis had an increasing glomerular filtra-
tion rate and sepsis was cured. Abdominal CT-scan performed 
during this hospitalization had shown a diffuse thickening of 
the gallbladder’s wall associated with stones as well as peri-
cholecystic fluid (Figure 1). The CT-scan didn’t highlight 
pathological findings on the liver, such as enlarged regional 
nodes. A dilated common bile duct with the presence, in its 
proximal portion, of tenuously hyperdense material was described.
Endoscopic ultrasound was performed, and it confirmed the 
presence of both gallbladder and common duct stones, the 
Figure 1. CT-scan showing a diffuse thickening of the gallbladder and inflammatory pericholecystic fluid.
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largest was 7 millimetres, and biliary sludge with lack of dilatation 
of the intrahepatic biliary tract. Several stones were removed 
via endoscopic retrograde cholangiopancreatography, and a 
nasobiliary tube was left behind. Subsequent cholangiography 
demonstrated the regular calibre and morphology of the cystic 
duct, the principal biliary tract, and the intrahepatic biliary tree. 
However, the gallbladder appeared distended with several 
little stones inside.
The patient, after 6 days from the admission, finally under-
went laparoscopic cholecystectomy. Intraoperative findings 
showed the gallbladder with thickened walls and densely fused 
with the liver but without other pathological findings. No intra-
operative complications occurred. Histological examination of 
the surgical specimen highlighted the presence of metastasis 
from an infiltrating ductal breast carcinoma with positive hormone 
receptors: Estrogen Receptors (MoAb SP1) 98%, Progester-
one Receptors (MoAb 1E2) 95%, Cytoprolferative Activity 
(MoAb MIB-1) 10%, c-erbB2 (MoAb 4B5) score: 0. The 
cystic lymph node showed no evidence of metastasis. The 
postoperative course was regular, and the patient was transferred 
to a rehabilitation ward five days after surgery.
After completion of the rehabilitation program, the patient was 
discharged, and hormone therapy (letrozole 2.5 mg once a day) 
was started. The patient died 15 months later due to peritoneal 
and bone progression of the disease.
Review of the literature
We conducted a systematic review in which all articles describ-
ing cases of gallbladder metastasis from breast cancer were 
considered eligible for inclusion. Abstracts, conference papers 
and studies concerning animals were excluded. No restric-
tions were applied to publication date or languages, if there was 
an English version of the article available.
A systematic search for articles published up to February 
2020 using PubMed, Scopus, Google Scholar and Web of 
Science databases was performed, and references of articles that 
were retrieved in the full text were also searched. The search 
strategy utilized in all databases included the combination of 
the keywords: “gallbladder metastasis”, “breast cancer”, “acute 
cholecystitis”, “biliary colic”, “cholelithiasis”. A minimum 
number of two search keywords were utilized, one of which 
was always “breast cancer”.
A total of 848 potentially relevant articles were retrieved in 
Google Scholar, 427 in Scopus, 182 in Web Of Science and 123 in 
PubMed. Among these 22 studies were identified to be strictly 
matched with our research (Figure 2). Our case was also 
included in the review.
Discussion
In consequence of advances in medical chemotherapy and 
endocrine therapy in the last years, the outcomes for breast 
cancer are improved. Disease recurrence is more common 
within five years of surgery while late recurrences after more than 
10 years are very uncommon. The literature outlines risk fac-
tors for late recurrence as lymph node metastases, ER + status 
and HER-2 negative status6,7. Breast cancer metastases occur 
through contiguous, lymphatic and hematogenous spread. It usu-
ally metastasizes to bone, lung, lymph nodes, liver and brain. 
Less frequently invaded are the endocrine organs, pericar-
dium, abdominal cavity and eyes. Metastasis in the extrahepatic 
digestive system are infrequent and characteristically appear 
after a long latent period, which takes from three to up to 20 
years5.
Concerning gallbladder metastases by breast cancer, autopsy 
findings have shown that secondary hematogenous metastases 
(also from other primary organs) to the gallbladder initially 
generate small flat nodules below the mucosal layer. They grow 
as a pedunculated tumor, rarely reaching higher than several 
millimetres in size. The growth pattern clarifies why gallblad-
der metastases rarely result in clinical symptoms and that they 
are not diagnosed during patients’ lives. Metastatic gallbladder 
tumors rarely show signs; acute cholecystitis is the most frequent 
clinical presentation8. Obstructive jaundice, haemobilia, even 
bile peritonitis due to perforation, are seldom described. When 
a gallbladder metastasis is identified after surgery, the primary 
tumor can be not easily defined. Distinguishing between primi-
tive gallbladder carcinoma and metastases from breast cancer is 
crucial for proper post-surgery therapy; in this way, immunohis-
tochemical evaluation is necessary. The most reliable markers 
are gross cystic disease fluid protein such as 15 (GCDEP -15), 
plus cytokeratin 7, cytokeratin 20, and estrogen and progester-
one receptors. Usually, their positivity is present in metastatic 
breast cancer, but not in all cases9.
At microscopic pathological examination, metastases are often 
represented by small clusters and chains of neoplastic cells, com-
monly of the signet-ring histotype. Pathological diagnosis of 
metastases from lobular breast cancer can be difficult because 
signet-ring cells could be present in tumors originating from 
different organs, such as the stomach10.
Our review of the literature conducted on secondary lesions 
of the gallbladder from breast cancer has confirmed the rar-
ity of this disease (see Table 1 for a summary of the cases). 
Gallbladder metastasis is only described in 23 patients, including 
our case: 11 from infiltrating lobular, 7 ductal origins, 3 mixed 
ductal and lobular infiltration, and 3 not specified. This analy-
sis reveals how, in most cases (12), the diagnosis of metastatic 
Page 4 of 13
F1000Research 2020, 9:343 Last updated: 15 OCT 2020
Figure 2. Flow diagram of articles included in the literature review.
lesions was made after surgery was performed for acute chole-
cystitis. There was evidence of gallstones in 8 cases; 9 cases 
were patients who often suffer from abdominal pain and/or 
vomiting (symptoms of biliary colic), and so they underwent an 
elective cholecystectomy. Only in 2 cases, the main symptom 
was obstructive jaundice or bile peritonitis for necrotic 
gallbladder.
Instrumental diagnostics are useless as they do not show 
significant data on gallbladder walls that are suspicious for 
malignancy; the identification of the neoplastic disease is pos-
sible only after surgery during histological examination of 
the specimen, as was shown in our case. From the analysis of 
the cases described in the literature, it follows that the most 
frequent tumor histology associated with gallbladder metastasis 
by breast cancer is infiltrating lobular carcinoma.
This review shows how the detection of gallbladder metasta-
sis usually occurs any time after the surgery for the primary 
tumor. In essence, we would highlight that in 6 cases, it 
happened after more than 10 years from primary surgery, in 
7 cases between 1 and 6 years, and 3 cases within the first year. 
Only in 6 cases was the detection of breast cancer and gallbladder 
metastasis synchronous.
Conclusions
This report emphasizes the importance of long-term follow 
up in patients with a history of breast cancer.
Our experience and data from the literature suggest carefully 
evaluating every anomaly observed during routine staging exami-
nations, even when apparently due to benign, mild disease. 
Metastatic disease always should be included in the differential 
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diagnosis of a patient with a history of invasive breast can-
cer and new onset of abdominal pain. Conventional methods 
of documenting gallbladder disease are nonspecific concerning 
the malignant disease. This may pose a diagnostic challenge in 
patients with abdominal symptoms after resection of malignan-
cies, also because they need to be aggressively treated as it can 
improve the poor prognosis of these cases. From our case and 
literature review, we recommend the following:
1. Consider the oncological story of the patients in 
the emergency setting;
2. Metastatic disease should be included in the 
differential diagnosis in patients with a history of 
breast cancer.
Consent
Written informed consent for publication of clinical details and 
clinical images was obtained from the patient on admission 
to hospital prior to the patient’s death.
Data availability
No data is associated with this article.
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